Skip to main content

Par C210 Pill - blue & yellow capsule/oblong

Pill with imprint Par C210 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Par Pharmaceutical Companies, Inc.

Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par C210

Fenofibric acid delayed-release 135 mg Par C210

Fenofibric Acid Delayed-Release

Imprint
Par C210
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Companies, Inc.
Inactive Ingredients
lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, stearic acid, magnesium silicate, triethyl citrate, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, D&C Yellow No. 10, ferrosoferric oxide, propylene glycol, shellac, FD&C Yellow No. 6, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
10370-0210 (Discontinued) Anchen Pharmaceuticals, Inc.
68084-0715 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.